Literature DB >> 16857334

[Use of cranberry in chronic urinary tract infections].

F Bruyère1.   

Abstract

OBJECTIVE: Chronic cystitis in women is frequent and difficult to treat. Up to now, an empirical prescription of antibiotics could decrease the frequency of acute episodes but with adverse effects and increasing risks of resistance. Studies have shown that cranberries should be used for that indication. We made a systematic review of literature to demonstrate how to use the cranberry.
RESULTS: Randomized studies confirmed that the proanthocyanidin contained in cranberries can eliminate Escherichia coli adhesion to the urothelium. Clinical studies showed that the incidence of acute cystitis decreased when treated by cranberries. On the other hand, patients with a neurogenic bladder and intermittent catheterization do not seem to benefit from the fruit. We did not find any study on postcoital use of cranberries. Various substances and doses were used in these studies and we could not conclude on best galenic presentation to prescribe.
CONCLUSION: Cranberries can inhibit E. coli adhesion to the urothelium and could be useful to treat urinary infections. Clinical studies confirm the probable benefit of this fruit as a prophylactic treatment for female cystitis. Prescriptions modalities remain to be defined.

Entities:  

Mesh:

Year:  2006        PMID: 16857334     DOI: 10.1016/j.medmal.2006.05.001

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  3 in total

Review 1.  Cranberries and lower urinary tract infection prevention.

Authors:  Marcelo Hisano; Homero Bruschini; Antonio Carlos Nicodemo; Miguel Srougi
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

Review 2.  Cranberry: Chemical Composition, Antioxidant Activity and Impact on Human Health: Overview.

Authors:  Boris V Nemzer; Fadwa Al-Taher; Alexander Yashin; Igor Revelsky; Yakov Yashin
Journal:  Molecules       Date:  2022-02-23       Impact factor: 4.927

3.  Cysticlean® a highly pac standardized content in the prevention of recurrent urinary tract infections: an observational, prospective cohort study.

Authors:  Francisco Sánchez Ballester; Vicente Ruiz Vidal; Emilio López Alcina; Cristina Domenech Perez; Eva Escudero Fontano; Ana Oltra Benavent; Ana Montoliu García; Marco Sobrón Bustamante
Journal:  BMC Urol       Date:  2013-06-05       Impact factor: 2.264

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.